Saniona

About:

Saniona is a research and development company with low burn rate, a world class team and high ambitions.

Website: https://www.saniona.com/

Twitter/X: https://twitter.com/saniona_ab

Top Investors: RA Capital Management, Michael J. Fox Foundation, New Leaf Venture Partners, Pontifax, Innovation Fund Denmark

Description:

Saniona is a pharmaceutical company focusing on the development and advancement of multiple potential new medicines through clinical trials. The company is pioneering in the development of highly selective ion channel modulators. Ion channel modulation is a well-established approach to disease treatment that has been used in medications for diabetes, hypertension, epilepsy, and other conditions. TesometTM, the company's most advanced product candidate, has advanced to mid-stage clinical trials for rare eating disorders. Saniona is advancing two product candidates, SAN711 and SAN903, using its ion channel expertise. A Phase 1 clinical trial of SAN711 for the treatment of neuropathic pain conditions was completed successfully. SAN903 is now ready for Phase 1 clinical trials to treat inflammatory and fibrotic disorders.